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Designing vaccines against infectious diseases, allergy or cancer with adjuvants is a central issue nowadays. The route of administration, the formulation and the type of the adjuvant can fundamentally determine the outcome of the immune response.
CpG motifs interact with TLR9 in the endolysosomal compartment from which host DNA is usually excluded and this ligand binding occurs at a particular stage of endosome maturation and acidification [1] . Interaction of TLR9 and its ligand stimulates an innate immune response characterized by the production of cytokines, chemokines and immunoglobulins by lymphocytes, macrophages, NK cells and DC [2] [3] [4] . In particular, the increased production of IL-12 promotes IFN-γ production by NK cells and T cells, and enhances the antigen-specific T cell proliferation and differentiation of naïve T cells towards the Th1 phenotype [5] . Most of the researchers have focused on the cellular activating effect of the signal transduction events that are triggered by TLR9 ligation while less is known about the modulation of antigen uptake by CpG ODN. Some authors mentioned the relevance of 'stickiness' of synthetic ODNs [6, 7] that can take part in the uptake of antigen and thus have an impact on the elicited immune response. There is evidence that ligation of CpG to a particulate antigen can enhance the uptake of CpG via endocytosis initiated by the antigen-specific BCR [8] .
However, when a non-specific B cell or other APC encounters a CpG-antigen conjugatewhich is probably a more common event in a physiological situation -has not been studied widely. Only indirect effects of CpG treatment on enhancement of microbe uptake by macrophages [9] or of amyloid β 1-42 peptide by microglial cells [10] were reported.
We have developed a modular system for experimental vaccination based on streptavidin 
Generation of bone marrow-derived dendritic cells (BMDC)
The principle method for generating BMDC with granulocyte-macrophage colony-stimulating factor (GM-CSF) was adapted from a previous publication [14] with the following modifications. BM was flushed from the femurs of BALB/c mice using a 21-gauge needle and glucose-potassium-sodium (GKN) buffer. After Tris-ammonium chloride lysis of RBC, BM cells were cultured in teflon bottles for 6 days at 37°C in 5% CO 2 humidified atmosphere at 10 6 cells/ml in complete RPMI 1640 medium, supplemented with GM-CSF. Recombinant murine GM-CSF concentration was adjusted to 34 ng/ml, based on ELISA (BD Biosciences, Franklin Lakes, NJ, US) measurement of the supernatant of a murine GM-CSF producing X63 mouse myeloma cell line (the kind gift of Zsuzsa Bajtay, ELTE, Budapest, HU).
According to the results of Zs. Bajtay, the usage of teflon bottles enhances the purity of the BMDC culture from 80% to about 92% (unpublished data). The expanded BM culture was incubated for one additional day without GM-CSF prior to further in vitro tests. Levels of antigen specific IgG1 and IgG2a were determined as described previously [12] .
In vitro cell activation
ELISA
Briefly, 96-well plates were coated first with SA (Sigma-Aldrich) and then with biotinylated 
Reverse ELISPOT assay
The number of antibody-secreting cells (ASC) in the draining LN after immunizations was determined as described previously [13] . Briefly, 5×10 5 cells, isolated from draining LN of immunized mice were incubated in quadruplicates for 20 h at 37ºC. Plates were then washed and incubated with SA-HRP (Sigma-Aldrich) conjugated to MycHH in equimolar amounts (1.67 nM) at 37ºC for 1 h. The spots were developed, the membranes were washed, dried and scanned, and the number of spots was determined by the ImmunoSpot software (C.T.L.).
Reverse Protein Microarray
Sera from all immunized mice were spotted individually onto nitrocellulose-covered glass 
MACS
For gene expression studies differentiated BMDC were positively separated from the BM culture with anti-mouse CD11c magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, DE) according to the manufacturer's protocols. FcRs were blocked by naive BALB/c serum.
Activated spleen suspension was separated to CD19 + (B cell) and CD19 -(T cell) populations with anti-mouse CD19 magnetic beads (Miltenyi Biotec). The purity of the resulting B and T cell suspensions was at least 95%.
Analysis of TLR9 gene expression by qPCR
RNA was extracted from magnetically separated CD19 positive B cells, CD19 negative T cells and CD11c positive BMDC using TRIzol reagent (Life Technologies, Carlsbad, CA, US) and converted to cDNA for real-time PCR analysis as described previously [15] . Realtime PCR was performed on an ABI PRISM 7000 Sequence Detection System (Applied 
Statistical analysis
Regarding in vitro experiments, all data were normalized to the data of SA treatment and statistical differences were assessed by pairwise comparisons of relevant groups using permutation tests with the help of the software R. Briefly, values from the groups to be compared were randomly reassigned to two groups and the difference between the group means was calculated. Distribution of 5000 randomizations was drawn and the two-tailed p value corresponding to the real sample assignments was determined. The arithmetic mean of 50 such p values was accepted as the probability of α-error. Values of p < 0.05 were considered significant and were indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
Statistical differences between the control and the experimental immunization groups were determined by nonparametric, Kruskal-Wallis ANOVA analysis for ELISA and ELISPOT and reverse protein array experiments, using Statistica 8 software (StatSoft). Quantitative data are expressed as individual data of mice; the horizontal lines indicate medians of the groups.
Levels of significance were indicated with asterisks as mentioned previously.
3.
Antigen-conjugated CpG enhances cellular association and uptake of the antigen by APC and T cells
We characterized the efficiency of antigen capture and uptake using fluorescently labeled SA.
Synthetic biotinylated CpG (ODN 1668) was mixed with SA in a 1:1 ratio and coincubated with bone marrow-derived dendritic cells (BMDC), and splenocyte suspension. B220 positive splenocytes were referred to as B cells, and B220 negative splenocytes were referred to as T cells. Conjugating CpG to the protein antigen resulted in enhanced association to B and T lymphocytes and BMDC after 24 h of incubation (Fig. 2) . To exclude that increased fluorescence was a result of SA-CpG sticking to the cell surface, SA accessibility was assessed by anti-SA antibodies. Weak or missing anti-SA signals indicated that cellular uptake was mainly responsible for CpG-mediated SA association to the cells (Fig. 2) . The level of APC activation was low because the doses of CpG used here were titrated to be suboptimal to allow modulation in the following competition studies. There was no difference between the activatory potential of SA + CpG and SA-CpG treatments (Fig. 2) .
Non-biotinylated excess CpG efficiently competes with CpG-antigen conjugates on BMDC and T cells, but shows weak or no competition on B cells
In order to prove that the increase in uptake of SA-CpG complexes compared to the uptake of SA alone is due to a receptor-mediated and therefore a saturable process we tested the effects of free CpG and other types of ODN on the SA-CpG uptake. In the presence of a 100-fold molar excess of free CpG, association of SA-CpG complexes to T cells and BMDC was robustly reduced. In contrast, the SA-CpG uptake of B lymphocytes could not be inhibited even with a 100-fold excess of free CpG (Fig. 3A) .
Although the addition of excess CpG resulted in enhanced B cell and BMDC activation, the difference between association of SA-CpG to the different cell types was not a consequence of the strong activation of B cells, since the same results were observed with excess CTRL (ODN 1720) that has little or no activating effect (Fig. 3B) . A TLR9 inhibitor ODN, marked INH (ODN 2088) showed competition with SA-CpG in the case of all three cell types though with less efficiency (Fig. 3C ). The addition of excess ODN had no effect on SA accessibility on the cell surface ( Supplementary Fig. 1A-C) , except in the case of B cells treated with SACpG + INH in 100-fold excess. In this last case the inhibitory ODN also competed with the low amounts of cell surface bound SA-CpG complexes ( Supplementary Fig. 1C ).
As the weak competition between free and antigen-conjugated CpG in B cells could not be explained by the activatory effect of excess CpG, we performed RT-PCR measurements to compare the expression of TLR9 in these cell types. Both in untreated and activated B cells, the expression of TLR9 was much higher compared to BMDC or T cells (Supplementary Fig.   2A -B), suggesting that saturation of the receptor would be more difficult to achieve in these cells.
CpG conjugation to SA elevates the level of antigen-specific antibodies
As we found that CpG facilitates the accumulation of a CpG-conjugated protein in DC and Fig. 5A-B) and ELISPOT (Fig. 6 ).
Free CpG adversely influences the adjuvant effect of antigen-CpG conjugation
To study the in vivo interactions between free CpG and SA-CpG complexes, we prepared a formulation where half of the CpG was conjugated to SA, and half of it was in free form.
Interestingly, instead of showing an additive effect, vaccination with the SA-CpG + CpG formulation did not enhance immune responses at all (Fig. 4B -Fig. 6 ). Antigen-specific Ab levels ( Fig. 4B , 5B) and the number of Ab secreting cells (Fig. 6) were comparable to the SA group where no CpG was present, and were significantly lower compared to the SA-CpG group. showed that a protein antigen efficiently accumulates in different leukocytes when it is linked to a TLR9 ligand, a single-stranded phosphorothioate-protected (PS) CpG ODN. The mechanism of CpG uptake is controversial, as non-specific internalization [16] as well as specific uptake mechanisms have been suggested. Various receptors and transfer molecules came into view as potential CpG binders, like CD14 [17] , membrane bound scavenger receptors like CXCL16 [18] or SR-A and MARCO [19] , DEC-205 [20] , human CR2 [21] , the KIR3DL2 receptor on human NK cells [22] , and alpha 2-macroglobulin [23] . It has also been proposed that the uptake of ODN that have a PS backbone differs from that of natural phosphodiester backboned ODN, and PS ODN bind to many proteins due to nonspecific interactions [24] . The number of these -sometimes controversial -studies shows that there is much to be done to elucidate the uptake mechanisms of CpG ODN or its synthetic analogues and to better understand the intracellular fate and mechanism of effect of complexes that consist of protein antigen and CpG. Whatever the internalization mechanism could be, our results point to a TLR9-mediated accumulation that can be saturated in cells where TLR9 expression is low. Of the two APC types we studied, splenic B-cells showed more than ten times higher expression of TLR9 compared to BMDC ( Supplementary Fig. 2 (Fig. 3) . Taken antagonists can also promote costimulation of anti-CD3 treated CD4 + T cells [25] .
Our immunization studies suggest that instead of showing additive immunostimulatory properties, antigen-conjugated and free CpG rather cancel out each other's effects. Both the number of antigen-specific ASC and the circulating Ab levels were comparable to immunizations with SA alone, and were significantly weaker than the SA-CpG induced effects (Fig. 4-6 ). We speculate that competition between SA-CpG complexes and free CpG occurs in DC in vivo, resulting in poorer antigen uptake or accumulation by these cells.
The amounts of CpG and antigen we used for immunizations (83.3 pmol/mouse) were set to be close to the minimum concentration that was needed to trigger cell activation in vitro (5 pmol for 10 6 spleen cells or 10 pmol for 2×10 5 BMDC). By comparison, in other vaccination studies where the aim was to elicit a strong immune response against the injected antigen, orders of magnitude higher amounts of CpG were used [29] [30] [31] . In contrast to these studies, the concentration we used might be rather suitable for monitoring subtle differences between the immunomodulating effects of immunization with materials of similar composition but different formulation. Our purpose was also to avoid systemic reactions known to be induced 
